Rohin Patel

Item: Rohin Patel
Rating: 2.14
Author: StockAnalysis.com

Stock Analyst at JP Morgan

(2.14)

# 2,834

Out of 5,116 analysts

Total ratings

66.67%

Success rate

10.9%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Rohin Patel

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	HAE Haemonetics	Maintains: Neutral	$62 → $74	$80.28	-7.82%	3	Dec 12, 2025
	NPCE NeuroPace	Maintains: Overweight	$18 → $20	$16.02	+24.84%	2	Dec 10, 2025

Haemonetics

Dec 12, 2025

Maintains: Neutral

Price Target: $62 → $74

Current: $80.28

Upside: -7.82%

NeuroPace

Dec 10, 2025

Maintains: Overweight

Price Target: $18 → $20

Current: $16.02

Upside: +24.84%